This article and associated images are based on a poster originally authored by Sophie O’Neil, Kyle Thompson, Rita Pereira, Emily Russell and Stuart McElroy and presented at ELRIG Drug Discovery 2025 ...

A new study suggests that the long-term antidepressant effects of psychedelics may be driven by persistent changes in how ...

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in ...

Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia February 3, 2026 10:30 ...

Researchers at the UC Davis Department of Chemistry and Institute for Psychedelics and Neurotherapeutics have come up with a new technique to create candidate drugs that engage the serotonin receptor ...

Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a jolt and setting up future registrational trials for the serotonin receptor ...

Learn to manage bipolar medication side effects such as weight gain, drowsiness, and brain fog with lifestyle changes and ...

EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu RxConnect® pharmacies to support ...